@article{111201,
  author = {Mu Yang and Wei Bao and Xinmin Zhang and Yibin Kang and Bruce Haffty and Lanjing Zhang},
  title = {Short-term and long-term clinical outcomes of uncommon types of invasive breast cancer},
  abstract = {<p>AIMS: Invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) are predominant and well-documented types of invasive breast cancer (IBC). We investigated the clinical outcomes of other types of IBC (i.e. uncommon IBC), which collectively account for Σ20\% of all IBC cases, as these are largely unknown. METHODS AND RESULTS: We identified all IBC cases diagnosed in 2004-2006 (n = 159 293) and 2010-2011 (n = 118 822) from the Surveillance, Epidemiology and End Results (SEER) database. Uncommon IBCs included mixed IDC and ILC (MDLC), IDC mixed with other types of carcinoma, ILC mixed with other types of carcinoma, and other-type breast cancers (OCs). We estimated overall survival (OS) and cancer-specific survival in multivariate regression models. As compared with IDC, MDLC was associated with an increased OS [adjusted hazard ratio (aHR) = 0.92, P</p>
},
  year = {2017},
  journal = {Histopathology},
  volume = {71},
  pages = {874-886},
  month = {12/2017},
  issn = {1365-2559},
  doi = {10.1111/his.13328},
  language = {eng},
}